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Doreen A. Wüstenhagen1, Péter Kele5, Stefan M. Schiller2,3,4 & Stefan Kubick1
Cell-free protein synthesis systems represent versatile tools for the synthesis and modification of 
human membrane proteins. In particular, eukaryotic cell-free systems provide a promising platform for 
their structural and functional characterization. Here, we present the cell-free synthesis of functional 
human epidermal growth factor receptor and its vIII deletion mutant in a microsome-containing 
system derived from cultured Sf21 cells. We provide evidence for embedment of cell-free synthesized 
receptors into microsomal membranes and asparagine-linked glycosylation. Using the cricket paralysis 
virus internal ribosome entry site and a repetitive synthesis approach enrichment of receptors inside 
the microsomal fractions was facilitated thereby providing analytical amounts of functional protein. 
Receptor tyrosine kinase activation was demonstrated by monitoring receptor phosphorylation. 
Furthermore, an orthogonal cell-free translation system that provides the site-directed incorporation 
of p-azido-L-phenylalanine is characterized and applied to investigate receptor dimerization in the 
absence of a ligand by photo-affinity cross-linking. Finally, incorporated azides are used to generate 
stable covalently linked receptor dimers by strain-promoted cycloaddition using a novel linker system.
Cell-free protein synthesis (CFPS) has emerged to be a versatile tool for the synthesis of difficult-to-express pro-
teins including membrane proteins1. Nevertheless, functional and structural investigations of membrane proteins 
using conventional cell-free systems generally require the addition of supplements such as detergents, surfactants 
and membrane mimetics to facilitate proper protein folding2. Alternatively, laborious re-folding strategies become 
essential to obtain native and functional products3. A promising alternative to these conventional systems has been 
developed, which is based on cell extracts derived from cultured Sf21 cells4. This system contains microsomal struc-
tures originating from the ER, which provide a nature-like membranous environment that can serve as a platform 
for structural and functional in vitro investigations of properly folded and post-translationally modified membrane 
proteins5. The yields typically obtained in the Sf21 system are in the range of several μ g per ml6. To improve the sys-
tem’s productivity, viral internal ribosome entry sites (IRES) have been reported to increase total protein yields. In 
particular, the use of IRES elements that promote protein translation independent of eukaryotic initiation factors, 
such as the cricket paralysis virus IRES (CrPV-IRES), circumvent a major bottleneck observed in eukaryotic CFPS7.
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Orthogonal translation systems facilitating the incorporation of non-canonical amino acids have gained much 
attention over the last decades, providing researchers with efficient tools to implement desired characteristics into 
proteins in a site-directed manner8–11. In this context, CFPS offers several advantages that arise from the direct 
accessibility of the protein translation process12. Orthogonal suppressor tRNA/synthetase pairs mediating the 
incorporation of non-canonical amino acids by stop codon suppression, can now be supplemented directly to 
the open cell-free system in a purified form, together with high concentrations of non-canonical amino acids in 
order to achieve optimal incorporation efficiencies. A widely used example of such a non-canonical amino acid 
is p-azido-L-phenylalanine (AzF), which can be used for protein interaction studies due to its photosensitivity13. 
Furthermore, AzF is known to selectively react under physiological conditions via a set of different reactions such 
as Staudinger ligation, copper-catalyzed alkyne-azide cycloadditions and copper-independent strain-promoted 
alkyne-azide cycloadditions14. In this context, bioorthogonal chemistry facilitates functional analysis of mem-
brane proteins.
A prominent example of a sophisticated eukaryotic transmembrane protein is the epidermal growth factor 
receptor (EGFR), representing one of the best-studied human receptor tyrosine kinases. It is involved in a variety 
of processes that support cell viability and regulate cell-growth, differentiation and migration15. Correspondingly, 
malfunction has been connected to a variety of diseases and EGFR signaling plays a pivotal role in different 
types of cancer16. The EGFR is a high-molecular weight glycoprotein of approximately 180 kDa with a single 
transmembrane-spanning segment that connects its extracellular domains, including the ligand binding site to 
the intracellular domains, comprising a tyrosine kinase domain followed by a highly dynamic C-terminal tail. 
Upon activation, selected residues in the C-terminal tail are phosphorylated that serve as recognition sites for dif-
ferent adapter molecules thereby translating extracellular signals into the cell17. Dimerization is the predominant 
model describing signal transduction initiation of the EGFR. Interestingly, besides ligand induced dimer forma-
tion, the EGFR has also been found to dimerize in the absence of a ligand18. Moreover, even autophosphorylation 
activity has even been described to occur without bound ligand, which seems to be promoted by a high receptor 
density inside the membrane19. Until today, the mechanistic details of receptor tyrosine kinase transactivation in 
the absence of a ligand remain poorly understood.
In this study, we describe the CrPV-IRES-mediated cell-free synthesis of the full-length glycosylated EGFR 
in a microsome-containing Sf21 system. Furthermore, an enrichment of receptors in the Sf21 microsomes is 
achieved either by a repetitive synthesis approach or a combination of IRES-mediated synthesis together with 
supplementation of the reaction with poly G. The receptor’s embedment in the microsomal membranes is veri-
fied and functionality in the absence of ligand, supported by increased receptor densities inside the membranes, 
is assessed by detection auf receptor phosphorylation. Finally, the ability of an orthogonal cell-free translation 
system (OcfTS) composed of a mutant E. coli tyrosyl-tRNA synthetase and a natural amber suppressor tRNACUA 
to incorporate the non-canonical amino acid p-azido-L-phenylalanine (AzF) into cell-free synthesized EGFR at 
different positions in a site-directed manner and with high fidelity is demonstrated. Based on its inherent char-
acteristics, the incorporated azido group is further utilized to gain evidence on receptor dimerization through 
photo-cross-linking. In this context, the generation of covalently linked synthetic EGFR dimers is facilitated by a 
novel homobifunctional COMBO linker system.
Results
Cell-free synthesis and characterization of functional EGFR. The synthesis of EGFR-eYFP based 
on the standard conditions previously described for the cell-free Sf21 system6 yielded relatively low amounts of 
several μ g/ml within 90 minutes of reaction time (Fig. 1a). Although the successful synthesis of the EGFR-eYFP 
fusion protein was verified by different means (Fig. 1a–c), ligand-independent receptor activation based on auto-
phosphorylation of Y1068 was not detectable (data not shown). Therefore, a batch of inherent Sf21 microsomes 
was repeatedly addressed by four consecutive cell-free reactions in order to enrich the cell-free synthesized EGFR-
eYFP in the microsomal fraction and potentially promote ligand-independent receptor activation (Fig. 1a–c). As 
a result, an almost 3-fold increase of de novo synthesized EGFR was detected in the microsomal fraction yielding 
nearly 10 μ g/ml of total protein (Fig. 1c,a, respectively). Autoradiography of isotopically labeled proteins revealed 
the predominant cell-free synthesis of two variants of the full-length receptor migrating at an apparent molec-
ular weight slightly higher than the calculated 163 kDa (Fig. 1b). It should be noted that all cell-free reactions 
and assays presented within this study were performed in the presence of the caspase inhibitor Z-VAD-FMK to 
prevent degradation of cell-free synthesized EGFR, which was observed during a prolonged incubation in the 
reaction mixture in the absence of the inhibitor (Supplementary Fig. 2). Interestingly, the relative increase of 
fluorescence based on the eYFP fusion showed a higher increase with each additional cell-free reaction than was 
observed for the total protein (Fig. 1c). As expected, fluorescent spheres in the confocal image of the microsomal 
fraction taken under hypo-osmotic conditions after four consecutive cell-free reactions reflected the EGFR-eYFP 
fusion protein to be localized at the microsomal membranes, thereby supporting the hypothesis of membrane 
embedment due to a directed translocation mediated by the N-terminal melittin signal peptide in the cell-free 
environment (Fig. 1d). Finally, this enabled the detection of the Y1068 (corresponds to Y1090 in the synthesized 
construct including the melittin signal peptide) phosphorylation after incubation of the microsomal fraction in 
kinase buffer in the absence of ligand (Fig. 1e).
Although the repetitive synthesis enabled assessment of the functionality of cell-free synthesized EGFR-eYFP, 
the underlying methodology is comparatively laborious as well as time and material consuming. Each reaction 
needs to be individually constituted using fresh components followed by consecutive incubation steps. Thus, in 
order to increase the yield in a single batch reaction, the influence of the CrPV-IRES was investigated, which 
has been described to provide an enhanced synthesis rate in different eukaryotic cell-free systems due to protein 
translation proceeding independent of initiation factors7. Additionally, the supplementation with poly G was 
investigated, which has been reported to inhibit RNase activity in a cell-free wheat germ system20. The CrPV-IRES 
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was implemented into the corresponding vector upstream of the EGFR-eYFP gene with the ATG start codon 
of the melittin signal sequence substituted by GCT (Fig. 2a). In this way, total protein yields were increased in 
the supernatant as well as in the microsomal fraction. An additional increase in protein yield was observed in 
the presence of poly G (Fig. 2b and Table 1, WT). The increase in total protein yield was slightly higher than the 
increase in fluorescence of the eYFP fusion protein. IRES-mediated synthesis in the presence of poly G provided 
the highest increase with 12.8 μ g/ml in the supernatant fraction and 8 μ g/ml in the microsomal fraction, whereas 
supplementation with poly G completely inhibited cell-free protein synthesis using the DNA template without 
IRES (data not shown). The reaction lifetime was not prolonged and remained at 90 to 120 minutes accord-
ing to the reaction lifetime of the standard reaction without IRES (Supplementary Fig. 3). Protein integrity of 
IRES-mediated cell-free synthesized EGFR-eYFP in the presence of poly G was verified by SDS-PAGE followed 
by autoradiography. Treatment of reaction aliquots with PNGase F and Endo H revealed the before-mentioned 
two protein variants representing the N-glycosylated as well as non-glycosylated form of the receptor (Fig. 2c).
As the localization of the EGFR-eYFP fusion protein was found to be at the microsomal membranes (Fig. 1d) 
and protein N-glycosylation as well as proper folding and corresponding functionality would most likely require 
the receptors to be integrated into the microsomal membranes in a defined orientation, a protease protection 
assay with proteinase K was performed (Fig. 2d,e). Proteolysis of cell-free synthesized EGFR-eYFP on intact Sf21 
microsomes resulted in a defined degradation product migrating in good agreement with the size of approxi-
mately half of the receptor fusion protein, thereby reflecting partial protection by the microsomal membranes 
(Fig. 2d). Disruption of the membrane integrity by addition of detergent led to almost complete protein deg-
radation due to access of the protease to cleavage sites within the entire receptor (Fig. 2e). Therefore, it can be 
concluded that the cell-free synthesized EGFR-eYFP is cotranslationally translocated into the Sf21 microsomal 
membranes mediated by the N-terminal melittin signal peptide. Nevertheless, the membrane integration seemed 
to be incomplete, reflected by the higher increase of protein yields in the supernatant fraction compared to the 
Figure 1. Enrichment of functional EGFR-eYFP in the Sf21 microsomal fraction by repetitive cell-free 
synthesis. (a) Total protein yields after each cell-free reaction in the complete reaction mixture (R), the 
supernatant fraction (S) and the microsomal fraction (M). Error bars represent the standard deviation of 
triplicate analysis. (b) Autoradiography of corresponding samples after electrophoretic separation under 
denaturing conditions. (c) Yields of total protein and eYFP fluorescence after each cell-free reaction relative 
to the first reaction. (d) Confocal fluorescence image of EGFR-eYFP in microsomal fraction taken under 
hypoosmotic buffer conditions. (e) Western Blot of microsomal fractions with and without EGFR-eYFP after 
incubation in kinase buffer. Isotopic labeling was achieved by 14C-leucine supplementation. The western blots 
(e) have been adapted in contrast, brightness and sharpness for better visibility. The original images can be 
found in Supplementary Fig. 1.
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Figure 2. IRES-mediated cell-free synthesis of N-glycosylated EGFR-eYFP and its embedment in Sf21 
microsomal membranes. (a) Schematic representation of standard (top) and IRES template (bottom) including 
regulatory elements. (b) Yields of total protein and eYFP fluorescence obtained using the standard (− IRES) or 
IRES template (+ IRES) in the absence (− PG) or presence of poly G (+ PG) relative to the standard reaction 
(− IRES, − PG). Error bars represent the standard deviation of triplicate analysis. (c–e) Autoradiography of 
IRES-mediated synthesis reactions in the presence of poly G after electrophoretic separation. c) Deglycosylation 
assay of complete reaction mixtures with Endo H or PNGase F. (d,e) Protease protection assay of microsomal 
fractions with Proteinase K in the absence (− Detergent) or presence of Triton X-100 (+ Detergent). Isotopic 
labeling was achieved by 14C-leucine supplementation.
Template Fraction IRES
Poly 
G
Total protein 
[μg/ml]
WT
Supernatant fraction
− − 2.10 ± 0.16
+ − 5.65 ± 0.15
+ + 12.84 ± 0.68
Microsomal fraction
− − 2.37 ± 0.60
+ − 6.28 ± 0.27
+ + 8.04 ± 1.30
Amb
Supernatant fraction
− − 0.51 ± 0.05a
+ − 0.34 ± 0.04a
+ + 4.47 ± 0.40a
Microsomal fraction
− − 0.07 ± 0.02a
+ − 1.29 ± 0.16a
+ + 2.66 ± 0.50a
Table 1.  Total protein yields of wild type EGFR-eYFP (WT) and full-length suppression product (Amb) 
obtained using the corresponding standard as well as the IRES template in the absence and presence of 
poly G, respectively. Errors represent the standard deviation of triplicate analysis. aTotal protein yields were 
estimated from the eYFP fluorescence of the suppression product in relation to the calculated total yields and 
eYFP fluorescence of the wild type protein synthesized under identical conditions.
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microsomal fraction (Fig. 2b). Washing of the microsomes with urea revealed roughly 75% of receptor molecules 
to be integrated into the lipid bilayer (Supplementary Fig. 4). Although the attempt to increase the efficiency 
of membrane integration by supplementing higher amounts of Sf21 microsomes was successful and the por-
tion of glycosylated receptor molecules increased, as a consequence the phosphorylation activity was abolished 
(Supplementary Fig. 5). Therefore, the amount of microsomes was left unchanged in the following experiments.
An orthogonal cell-free translation system for AzF incorporation. We previously established an 
OcfTS based on the microsome-containing Sf21 extract and expanded by a mutant E. coli tyrosyl-tRNA syn-
thetase together with a natural suppressor tRNACUA21. Based on these results, cell-free reactions were carried out 
in the linked mode enabling the co-translational incorporation of AzF by amber suppression with good fidelity 
upon addition of appropriate mRNA templates. Unfortunately, synthesis of the wild type EGFR-eYFP from a 
DNA template without internal amber codon in the coupled variant of the OcfTS, were mRNA transcription 
and protein translation were carried out in the same reaction vessel, and subsequent treatment with a fluorescent 
phosphine dye, revealed selective Staudinger ligation due to misincorporation of AzF (Supplementary Fig. 6). 
Selected controls revealed this to arise from an insufficient specificity of the mutant synthetase AzFRS for the sup-
pressor tRNACUA. Therefore, an additional mutation (R265) was introduced into the synthetase gene according 
to Takimoto et al. in order to enhance the enzyme’s recognition of the CUA anticodon22. The resultant enhanced 
mutant synthetase eAzFRS provided an increased incorporation efficiency of AzF (Supplementary Fig. 7) 
but more important also facilitated a higher specificity of incorporation using standard reaction conditions 
(Supplementary Fig. 6).
With the aim to further increase the yields of full-length suppression product, we investigated the influence 
of IRES-mediated synthesis and poly G in the coupled OcfTS. For this purpose, amber codons were introduced 
into the EGFR-eYFP templates with and without IRES, at the position corresponding to amino acid 687 in the 
translated receptor (corresponds to V665 in the wild type receptor without signal peptide) and synthesis of the 
full-length suppression product was measured based on fluorescence of the eYFP moiety only being translated 
upon successful amber suppression. Without additional Mg2+, which was previously described to enhance the 
productivity of the OcfTS6, only a small amount of suppression product was synthesized using standard condi-
tions. The suppression product was predominantly found in the supernatant fraction (Fig. 3a, − IRES, − PG). 
Using the IRES template and adjusted buffer conditions7 with elevated levels of K+ and Mg2+, yields increased in 
the microsomal fraction in the absence of poly G (Fig. 3a, + IRES, − PG). According to the findings for the wild 
type protein, highest yields were obtained using the IRES template and supplementing the cell-free reaction with 
poly G (Fig. 3a, + IRES, + PG). In accordance with the results obtained for the wild type EGFR-eYFP (Fig. 2b), 
the increase in the supernatant fraction was higher than in the microsomal fraction (Fig. 3a). Total yields of the 
suppression product, estimated from corresponding yields of the wild type protein, were 4.47 μ g/ml in the super-
natant fraction and 2.66 μ g/ml in the microsomal fraction (Table 1, Amb). The incorporation of AzF, using the 
adapted conditions, was verified by selective Staudinger ligation of cell-free synthesized receptors in the microso-
mal fraction with the fluorescent phosphine dye (Fig. 3c, Amb). The specificity of incorporation was found to be 
good, as no fluorescence modification was detected for the wild type control (Fig. 3c, WT).
Ligand-independent dimerization. In order to investigate ligand-independent dimerization in the 
microsomal membranes, a set of amber mutants was generated to introduce AzF into selected positions in the 
extracellular (Amb285, Amb307) and intracellular domains (Amb687) of the cell-free synthesized EGFR-eYFP. 
Additionally, a double mutant (Amb285 + 687) and an amber variant of the constitutively active vIII deletion 
mutant of the EGFR (vIII-Amb420) were generated. First, the suppression efficiency of the different amber 
Figure 3. IRES-mediated cell-free synthesis of EGFR-eYFP-AzF687 by amber suppression using an 
orthogonal tRNA/synthetase pair and subsequent chemo-selective fluorescence modification. (a) eYFP 
fluorescence obtained using the standard template (− IRES) and the IRES template with an amber codon 
at position 687 (+ IRES) in the absence (− PG) and the presence of poly G (+ PG). Error bars represent the 
standard deviation of triplicate analysis. (b) Autoradiography and (c) in-gel fluorescence of microsomal 
fractions from reactions performed using the IRES template without (WT) and with amber codon (Amb) in the 
presence of poly G after treatment with DyLight650 phosphine. Isotopic labeling was achieved by 14C-leucine 
supplementation. NTC: control reaction without DNA template.
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variants in the OcfTS was analyzed in relation to the synthesis of the corresponding receptor from templates with-
out internal amber codon (Fig. 4a and Supplementary Fig. 8). All mutants were successfully synthesized but with 
varying efficiencies. The suppression efficiency decreased the more distant the amber codon was located down-
stream of the ATG start codon in the full-length EGFR-eYFP constructs. The extracellular mutants Amb285 and 
Amb307 exhibited more than 60% and the intracellular mutant Amb687 roughly 50% of suppression efficiency. 
The combination of two internal amber codons led to a further decrease of suppression efficiency down to 25%. 
This efficiency is in good accordance to previously published results, since suppression of multiple amber codons 
in general is reported to be very inefficient23. The amber variant of the vIII-deletion mutant Amb420 (corresponds 
to Amb687 in the full-length EGFR), which lacks 267 amino acids in the extracellular domain24, exhibited the 
highest suppression efficiency above 80%.
Based on the ability to photo-activate AzF13 we next performed a cross-linking experiment using the micro-
somal fractions enriched with the different EGFR-eYFP mutants by four consecutive cell-free reactions, in order 
to investigate dimerization of cell-free synthesized receptors inside the microsomal membranes in the absence 
of ligand. The mutated sites in the extracellular region were chosen according to interacting residues found 
in the dimerization loop based on a crystal structure of the soluble extracellular region of EGFR with bound 
ligand25. Although all amber mutants exhibited autophosphorylation activity (Fig. 4c), no cross-linked dimers 
were found when AzF was incorporated in the extracellular dimerization loop (Fig. 4b,c). In contrast, a portion 
of cross-linked dimers was observed when AzF was incorporated at position 687, which is located in the intra-
cellular juxtamembrane region. Additionally, the vIII deletion mutant with AzF incorporated at the position 420, 
which corresponds to 687 in the full-length receptor, also revealed partial cross-linking. Overall, these findings 
demonstrate the dimerization of cell-free synthesized EGFR and its vIII variant thereby emphasizing proper fold-
ing and functionality of the receptors inside the Sf21 microsomal membranes.
Synthetic receptor dimerization. Finally, the two mutants that incorporate AzF in the intracellular jux-
tamembrane domain were used to exploit a novel cross-linking agent composed of two COMBO groups con-
nected by a tetraethylene glycol linker in order to form stable, covalently linked receptor dimers (Fig. 5a). For 
that purpose, the EGFR-eYFP-AzF687 and the vIII-AzF420 mutants were enriched in the microsomal fractions 
by four consecutive cell-free reactions. Both proteins were subsequently treated with the bis-COMBO linker in 
kinase buffer in the absence of ATP. Following the cross-linking, aliquots were subjected to the tyrosine kinase 
assay to analyze the phosphorylation of covalently linked dimers. Autoradiography of isotopically labeled proteins 
revealed weak but distinct proteins migrating at approximately the molecular weight corresponding to receptor 
dimers (Fig. 5b). In contrast, the controls synthesized from the wild type constructs without internal amber 
codon were not cross-linked, underlining the specificity of the reaction between the incorporated azides and 
the COMBO groups. The amount of cross-linked dimers, estimated from the autoradiogram, was approximately 
4% for EGFR-eYFP-AzF687 and 10% for vIII-AzF420 (Supplementary Fig. 11). Further, the phosphorylation of 
Y1068 was found to occur even in the pre-linked dimers, when incubated in kinase buffer in the presence of ATP 
(Fig. 5c).
Discussion
In this study, we have demonstrated the cell-free synthesis of functional human EGFR in a microsome-containing 
system derived from cultured Sf21 cells that supports signal peptide mediated cotranslational translocation of 
Figure 4. Suppression efficiency of different EGFR-eYFP amber variants and photo-affinity cross-linking 
of receptors in Sf21 microsomal membranes. (a) Suppression efficiency of EGFR-eYFP templates with amber 
codons at positions 273, 285, 307, 687, 285 + 687 and vIII-deletion mutant at position 420 based on eYFP 
fluorescence from complete reaction mixture in relation to wild type and vIII template without amber codon. 
Error bars represent the standard deviation of triplicate analysis. (b) Autoradiography and (c) western blot of 
phosphotyrosine 1068 of selected constructs enriched in microsomal fraction by four consecutive cell-free 
reactions after photo-affinity cross-linking in kinase buffer. Isotopic labeling was achieved by 14C-leucine 
supplementation. Asterisks mark the covalently cross-linked dimers. The autoradiogram (b) and western blot 
(c) have been adapted in contrast, brightness and sharpness for better visibility. The original images can be 
found in Supplementary Fig. 9.
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the high molecular weight type I transmembrane protein. Additionally, the cell-free system is capable of equip-
ping receptor molecules with N-glycans. Two different methodologies were investigated in order to increase the 
receptor concentration in the microsomal fraction, thereby promoting ligand-independent activation reflected 
by phosphorylation of Y1068 in an in vitro kinase assay. On the one hand, the standard conditions previously 
described for the cell-free Sf21 system6 were applied in order to enrich the receptor in the microsomal fraction 
by consecutive repetition of cell-free reactions performed with the same batch of Sf21 microsomes. On the other 
hand, DNA templates were equipped with the CrPV-IRES and synthesis was carried out using adapted buffer 
conditions and in combination with poly G. Although being comparatively laborious as well as time and material 
consuming, the repetitive incubation of Sf21 microsomes harboring cell-free synthesized EGFR-eYFP in fresh 
reaction mixture revealed a positive effect on protein folding reflected by the substantial increase in eYFP fluo-
rescence compared to the increase in total protein yields in the microsomal fraction. The established protein syn-
thesis technology enabled assessment of the functionality of cell-free synthesized EGFR-eYFP based on tyrosine 
phosphorylation. In comparison to the standard reaction, IRES-mediated protein synthesis provided an increase 
in total protein of 2.7-fold in the absence and 3.4-fold in the presence of poly G in the microsomal fractions within 
120 minutes of reaction time. A major bottleneck limiting overall yields in eukaryotic CFPS is thought to arise 
from the translation initiation event, in particular the availability of initiation factors26,27. Moreover, phosphoryl-
ation of eIF2-alpha has been found to occur in a stress-dependent manner in insect cells28, thereby preventing 
this eukaryotic initiation factor from being recycled to participate in further initiation events. Thus, the extract 
preparation procedure may have an additional impact on the phosphorylation status of eIF2-alpha. Therefore, 
the positive effect of the CrPV-IRES on protein yields can be explained by its underlying mechanism to provide 
translation initiation independent of host initiation factors7. Additionally, eIF2-alpha phosphorylation has been 
connected to the induction of caspases28, which underlines the benefit of supplementing cell-free reactions with 
the caspase inhibitor Z-VAD-FMK to prevent newly synthesized proteins from degradation. Interestingly, the 
influence of poly G, which was previously described to improve yields in a cell-free wheat germ system by inhibit-
ing RNases20, only enhanced protein yields in the context of IRES-mediated synthesis, but impaired protein pro-
duction when the standard conditions were applied. Therefore, we assume that inhibition of RNase activity does 
not seem to be the limiting factor in our system. In contrast, poly G may directly influence the IRES-mediated 
translation process. The underlying mechanism however still needs to be exploited.
Overall, it can be concluded that our approach increases the rate of cell-free protein synthesis while the reac-
tion lifetime remains unchanged. We amongst others have previously demonstrated that the reaction lifetime 
of the presented cell-free Sf21 system can be prolonged by performing reactions in a two compartment dialysis 
system29,30. This so called continuous exchange cell-free approach benefits from a feeding compartment, which 
is separated from the reaction compartment and allows for free diffusion of byproducts as well as energy equiv-
alents and building blocks through a semipermeable membrane. In this way, membrane protein yields of more 
than 100 μ g/ml have been reported using DNA templates lacking the CrPV-IRES used in this study. Although this 
approach increases the overall costs as well as time effort, it represents a valuable step towards the preparative 
scale production of target proteins thereby complementing our batch-based approach.
Figure 5. Selective cross-linking of receptors with incorporated AzF by strain-promoted cycloaddition 
using the bis-COMBO linker. (a) Schematic representation of cross-linking. Receptor- (blue) eYFP (yellow) 
fusion proteins are embedded in the membranes with incorporated AzF (N3) on the outside of the Sf21 
microsomal membranes. Treatment of the microsomal fractions with the bis-COMBO linker in kinase buffer 
in the absence of ATP leads to strain-promoted cycloaddition to form covalently linked receptor dimers. (b) 
Autoradiography and (c) western blot of phosphotyrosine 1068 of selected constructs enriched in microsomal 
fractions by four consecutive cell-free reactions, after treatment with bis-COMBO linker. Following the 
cross-linking samples were incubated in kinase buffer in the absence (− ) and presence of ATP (+ ) to allow 
for autophosphorylation. Isotopic labeling was achieved by 14C-leucine supplementation. Asterisks mark the 
covalently cross-linked dimers. The autoradiogram (b) and western blot (c) have been adapted in contrast, 
brightness and sharpness for better visibility. The original images can be found in Supplementary Fig. 10.
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The observation that the increase of total protein was more pronounced in the supernatant fraction than in 
the microsomal fraction indicated a partial integration of receptor molecules into the Sf21 microsomal mem-
branes. Treatment of the microsomes with urea further verified that in total approximately 75% of the cell-free 
synthesized receptors were membrane-embedded. This can be explained by an insufficient number of translocons 
to account for the increased protein translation rate observed when combining the IRES-mediated synthesis 
with the supplementation of poly G. In accordance, an increased amount of membrane-integrated receptors was 
observed when the amount of microsomes was increased in the cell-free synthesis reaction and likewise this pro-
vided more receptor molecules with attached glycans. In this context, it was also found that supplementation of 
higher amounts of Sf21 microsomes (250% and 500% in comparison to 100%) did not show any negative effects 
on total protein yields of EGFR-eYFP in the microsomal fraction. Nevertheless, increasing the amount of micro-
somes abolished the ligand independent activation of the EGFR, being in accordance with earlier findings that 
suggested a supportive effect of high receptor densities on its activation in the absence of ligand19. These results 
clearly demonstrate that the IRES-mediated cell-free synthesis represents a fast and economical method to pro-
duce satisfying amounts of functional EGFR for analytical purposes and the underlying cell-free system is highly 
tunable to meet desired requirements.
We further expanded the cell-free Sf21 system by an orthogonal tRNA/synthetase pair that provides the 
site-directed incorporation of AzF by amber suppression with high fidelity. Interestingly, we found the Arg265 
substitution in the mutant synthetase to not only increase the efficiency of AzF incorporation22, but also improve 
the specificity of incorporation in our cell-free Sf21 system. In accordance to the before-mentioned methodolo-
gies applied for wild type EGFR synthesis, the yields of full-length suppression product obtained in the resultant 
OcfTS were increased by utilization of DNA templates harboring the CrPV-IRES under adapted synthesis con-
ditions and supplementation of poly G. The investigation of different amber variants of the EGFR and the vIII 
deletion mutant revealed suppression efficiencies between 50% and 80% for single amber mutants and 25% for a 
mutant containing two internal amber codons. Compared to the efficiencies that can be obtained in cultured cells 
our cell-free system provides remarkable results without the need for further modifications targeted at release 
factors31 or the use of orthogonal ribosomes23.
Implicated by the assessment of phosphorylation and N-glycosylation in the cell-free microsome-containing 
environment, we were able to verify the embedment of EGFR-eYFP in the Sf21 microsomal membranes, most 
likely by active translocation mediated through the N-terminal melittin signal peptide. As ligand-independent 
activation was observed in the in vitro tyrosine kinase assay, we aimed at applying the novel OcfTS in order to 
investigate the dimerization of cell-free synthesized EGFR as well as the vIII deletion mutant. For that purpose, 
we enriched the transmembrane spanning EGFR amber variants in the microsomal fractions by four consecutive 
IRES-mediated synthesis reactions in the presence of poly G. Photo-affinity cross-linking revealed interaction 
of cell-free synthesized EGFR in the intracellular domains but not in the extracellular dimerization loop. This is 
in accordance with the proposed models of intramolecular tethers in the extracellular domain of the unliganded 
EGFR18. Therefore, we conclude that even though no direct contacts are present between the extracellular dimer-
ization loops of adjacent receptors, a portion of the receptors interact in their intracellular regions, most likely 
in accordance with the model of an asymmetric dimer, where the acceptor juxtamembrane domain is in direct 
contact with the donor C-lobe of the kinase domain32. Moreover, we detected interaction of AzF420 in the intra-
cellular region of the vIII deletion mutant, thereby promoting the findings of others, suggesting that asymmetric 
dimer formation seems to play a role in activation of the vIII mutant33. Finally, we generated stable covalently 
linked dimers of the EGFR-eYFP-AzF687 and vIII-eYFP-Amb420 using a novel bis-COMBO linker. We found 
phosphorylation to occur in the cross-linked dimers, indicating that the tetraethylene glycol linker provides 
enough freedom for the C-terminal tails to serve as substrates for the receptor tyrosine kinases. Nevertheless, if 
the phosphorylation of Y1068 in the covalent dimers is provided by their corresponding kinases or arises from 
the non-cross-linked receptors that are also present in the microsomal membranes still remains to be elucidated.
In conclusion, the presented synthesis approach represents a valuable platform for the analytical scale produc-
tion of functional membrane proteins within a short period of time. Furthermore, the resulting functionalized 
Sf21 microsomes enable the functional and structural characterization of membrane-embedded proteins in vitro 
and due to the direct accessibility of the de novo synthesized proteins, novel methodological approaches can be 
employed that may be difficult or even impossible when working in cell-based systems. In this context, the utiliza-
tion of non-canonical amino acids, in particular the ones that can selectively react via bioorthogonal chemistries 
such as the azide used in this study, bears a tremendous potential for elucidating structure-function relationships 
for instance using methods such as foerster resonance energy transfer. Thereby the amount of protein necessary 
can be significantly reduced and studies can be performed in a more complex and thus more native environment 
rather than on highly concentrated and purified proteins.
Methods
Template generation and site-directed mutagenesis. Generation of templates harboring the human 
EGFR gene with its native signal sequence substituted by the melittin signal sequence (Mel) and fused to eYFP 
(pIX3.0-Mel-EGFR-eYFP) as well as generation of the mutant E. coli tyrosyl-tRNA synthetase genes AzFRS 
(Thr37, Ser182, Ala183; pXAzFRS-SII) and eAzFRS (Thr37, Ser182, Ala183, Arg265; pQE2-eAzFRS-SII) both 
followed by a StrepTag II (SII; IBA) has been described previously6. The plasmid pIX4.0-Luc-His-Amb14 was 
purchased from RiNA (RiNA GmbH, Berlin, Germany). All plasmids used in this work harbor the T7 promoter 
and terminator sequences upstream and downstream of the ORFs, respectively. To introduce the CrPV-IRES the 
corresponding region was excised from a pIX3.0-CrPV-Mel-eYFP vector using NotI and BstZ17. The pIX3.0-
Mel-EGFR-eYFP was cut likewise and dephosphorylated using CIP (calf intestinal alkaline phosphatase, NEB) to 
prevent religation of the linearized plasmid. Finally, the CrPV insert was ligated into the linearized vector pIX3.0-
Mel-EGFR-eYFP to obtain pIX3.0-CrPV-EGFR-eYFP. Amber stop codons were introduced into the EGFR 
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gene by PCR using mismatch primer pairs. The integrity of all generated constructs was verified by sequenc-
ing. Plasmid preparations suitable for cell-free protein synthesis were performed using the JETSTAR Plasmid 
Purification Kit (GENOMED) starting from transformed E. coli XL10-Gold ultracompetent cells (Agilent).
Cell-free protein synthesis and incorporation of AzF. Preparation of the microsome-containing 
Sf21 extract as well as coupled cell-free protein synthesis using standard conditions have been described pre-
viously6,7. In brief, cell-free reactions from templates without CrPV-IRES were constituted using three different 
stable premixes stored at − 80 °C. Premix A (10x) was composed of 300 mM HEPES-KOH (pH 7.6), 750 mM 
KOAc, 2.5 mM spermidine, 1 mM of the 20 standard amino acids each (Merck) and 29 mM Mg(OAc)2. Premix B 
(2.5x) contained the S7 nuclease-treated Sf21 extract supplemented with 250 μ g/ml creatine kinase (Roche) and 
50 μ g/ml bulk yeast tRNA (Roche). Premix C (5x) consisted of 100 mM creatine phosphate, 8.75 mM ATP, 1.5 mM 
CTP, 1.5 mM UTP, 1.5 mM GTP (Roche) and 1.65 mM G(ppp)G cap analogue (Prof. Edward Darzynkiewicz, 
Warsaw University, Poland). First, the volume of additional RNase-free water necessary to sum up to the final 
reaction volume of 50 μ l was calculated and pipetted into a 1.5 ml reaction tube. Next, 5 μ l of premix A and 
20 μ l of premix B were added. Then, the caspase inhibitor Z-VAD-FMK (benzyloxycarbonyl-Val-Ala-Asp(OM
e)-fluoromethylketone, Promega) was supplemented at a final concentration of 30 μ M and T7 RNA polymerase 
(Agilent) was added to a final concentration of 1 U/μ l. Finally, 10 μ l premix C was added and the protein synthe-
sis reaction was initiated by addition of template DNA at a final concentration of 60 ng/μ l. Isotopic labeling was 
achieved by supplementation of 14C-leucine at 20–60 μ M (specific radioactivity 25–65 dpm/pmol, Perkin Elmer). 
It should be noted that all components and premixes were thawed on ice, gently mixed and then stored on ice 
during the time of constituting the cell-free reactions. Moreover, after addition of each component, the reaction 
solution was gently mixed by slowly pipetting up and down and after addition of the template DNA the reac-
tion mixture was gently mixed and spun down at 800 × g. Incubation was carried out at 27 °C and gentle shak-
ing for 90–120 minutes (Thermomixer comfort, Eppendorf). Cell-free reactions from templates harboring the 
CrPV-IRES were constituted likewise but with a slightly different composition of premix A containing 2250 mM 
KOAc and 39 mM Mg(OAc)2. Poly G (30 base pair primer, IBA) was added at a final concentration of 10–15 μM 
by substituting the remaining RNase-free water (for comparison of total protein yields 14 μ M were applied).
Enrichment of the EGFR-eYFP was achieved by repeated synthesis using the same batch of Sf21 microsomes. 
Therefore, the microsomal fraction was collected by centrifugation at 16,000 × g and 4 °C for 10 minutes after 
the first synthesis and resuspended in fresh reaction mixtures using the supernatant of premix B after a likewise 
centrifugation step. This procedure was repeated 3 times to result in four consecutive cell-free reactions.
The preparation of the mutant tyrosyl-tRNA synthetases was carried out as previously described6,21. The 
in vitro transcribed suppressor tRNACUA was purchased from RiNA (RiNA GmbH). Site-directed incorporation 
of AzF was achieved by supplementation of cell-free reactions with 2 μ M eAzFRS, 2 μ M tRNACUA and 2 mM AzF 
(Bachem). Incubation was performed in the dark as described above.
Determination of total protein yields. Following cell-free protein synthesis in the presence of 
14C-leucine, reactions were fractionated into the supernatant and the microsomal fraction by centrifuga-
tion at 16,000 × g and 4 °C for 10 minutes. Microsomal fractions were resuspended in equal volumes of PBS. 
Subsequently, aliquots of 5 μ l (from templates without IRES) and 2.5 μ l (from templates with IRES) were subjected 
to hot trichloroacetic acid precipitation and liquid scintillation counting. Analysis was performed in triplicates 
as described previously6. Total protein yields were calculated from measured disintegrations per minute (dpm) 
taking into account the specific radioactivity, the molecular mass and the number of leucines of the synthesized 
proteins.
Fluorescence detection of eYFP fusion proteins. The fluorescence of the eYFP fusion proteins was 
measured from 5 μ l aliquots of the corresponding fractions in 95 μ l PBS solution on 96 well microplates (Berthold) 
using the “Mithras2 LB 943 Monochromator Multimode Reader” (Berthold). Samples were excited at 485 nm and 
emission was detected at 530 nm. The background fluorescence of control measurements from cell-free reactions 
carried out under identical conditions but in the absence of a gene template was subtracted from the measured 
intensities. Confocal images of the microsomal fractions were taken under hypoosmotic conditions on a LSM 510 
meta (Zeiss) laser scanning microscope as described previously6.
Tyrosine kinase assay. To allow for in vitro autophosphorylation of receptors embedded in the Sf21 micro-
somal membranes, microsomal fractions from 10 μ l of the complete reaction mixture were collected and resus-
pended in 20 μ l kinase buffer composed of 100 mM HEPES (pH 7.4), 1% glycerol, 0.1 mg/ml BSA, 5 mM MgCl2, 
1.25 mM MnCl2, 0.1 mM Na3VO4, 2 μ M caspase inhibitor Z-VAD-FMK and 200 μ M ATP. Corresponding control 
reactions were performed using RNase-free water instead of ATP. Incubation was carried out for 30 minutes at 
room temperature.
Endoglycosidase and Proteinase K digestion. Endoglycosidase digestion with PNGase F and Endo H 
(NEB) was performed on 5 μ l aliquots of the complete reaction mixtures according to the manufacturer’s instruc-
tions, followed by denaturing PAGE and autoradiography as described below. The protease protection assay using 
Proteinase K was performed in a total volume of 10 μ l, containing 5 μ l aliquots of the microsomal fraction resus-
pended in PBS, 10 ng/μ l Proteinase K (Promega), 10 mM CaCl2 and either 1% Triton X-100 or PBS. Incubation 
was carried out for 0, 5, 15, 30, 90 minutes on ice and reactions were subsequently quenched with 6.25 mM phen-
ylmethylsulfonyl fluoride (PMSF) followed by immediate acetone precipitation.
Photo-affinity cross-linking. To analyze the interaction of cell-free synthesized receptors inside the Sf21 
microsomal membranes AzF was incorporated at different positions using the different templates with internal 
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amber stop codons. The mutant proteins were enriched by four consecutive cell-free reactions and subsequently 
the microsomal fractions (25 μ l) were resuspended in 50 μ l kinase buffer with ATP and transferred to a white 
“Nunc F96 MicroWell Polystyrene Plate”. Photo-cross-linking was achieved by incubation on ice for 2 hours 
under a UV handlamp at 365 nm followed by acetone precipitation, denaturing PAGE, immunoblotting and 
autoradiography.
Synthesis of bis-COMBO-TEG linker. All starting materials used in this work were obtained from com-
mercial suppliers (Sigma-Aldrich, Acros Organics, abcr, Alfa Aesar, Merck) and used without further purifica-
tion. A reaction scheme is given in Supplementary Fig. 12.
Chromatography. For reaction progress and purity control TLC was performed on TLC silica gel 60 F254 
aluminium sheets 20 × 20 cm from Merck. Visualisation was performed with a 254 nm UV lamp (low pressure 
Hg-Lamp from DESAGA) or by using an aqueous solution of KMnO4 (1.0 g KMnO4, 6.6 g K2CO3, 0.2 g NaOH in 
100 ml water). The purification of the products was carried out by column chromatography with Geduran® Si 60 
Silicagel (40–63 μ m) from Merck.
NMR-Spectroscopy. 1H- and 13C-NMR-Spectra were recorded on a Bruker ARX 300 spectrometer. The sol-
vent was used as reference signal. Chemical shifts (δ ) were given in parts per million (ppm) whereas the coupling 
constants (J) were reported in Hertz (Hz). Splitting patterns were designated as singlet (s), doublet (d), triplet (t), 
multiplet (m), doublet of doublets (dd) and broad singlet (bs).
All reactions were performed under inert gas (N2).
1,2,5,6-Tetrabromocyclooctane (1). A solution of 1,5-cis-cyclooctadiene (23.76 g, 0.22 mol) and CH2Cl2 
(250 ml) was cooled to − 78 °C. Br2 (81.12 g, 1.02 mol) in CH2Cl2 (200 ml) was slowly added to the cooled solu-
tion34. After the addition was completed the reaction mixture was warmed to room temperature and stirred for 
another 1 h. A saturated aqueous solution of Na2S2O3 was added and stirred for a few minutes. The suspension 
was filtered through Celite, the two phases were separated and the aqueous phase was extracted with CH2Cl2. The 
combined organic layers were dried over MgSO4 and the solution was almost concentrated to dryness. Hexane 
was added to the remaining solution facilitating crystallization. The crystals were filtered off and washed with 
cold hexane to obtain the desired product (58.50 g, 63%) as a lightly yellow solid that includes two isomers in a 
ratio of 54:46.
1H-NMR (300 MHz, CDCl3): Major isomer δ = 2.33–2.49 (m, 4 H), 2.49–2.62 (m, 4 H), 4.52–4.62 (m, 4 H). 
Minor isomer δ = 2.10 (d, J = 12.4 Hz, 4 H), 2.82 (d, J = 13.7 Hz, 4 H), 4.76 (d, J = 4.2 Hz, 4 H).
13C-NMR (75 MHz, CDCl3): Major isomer δ = 31.68, 58.44. Minor isomer δ = 26.81, 57.44.
Dibromocycloocta-1,5-diene (2). 1,2,5,6-Tetrabromocyclooctane (1) (58.0 g, 0.14 mol) was mixed with 
KOtBu (38.0 g, 0.34 mol) and cooled to − 78 °C. Then Et2O (400 ml) was added slowly to the mixture35. After 
completing the addition of Et2O the reaction mixture was allowed to warm up to room temperature and stirred 
overnight. The insoluble components were filtered off and washed with hexane. The organic phase was extracted 
with saturated aqueous NH4Cl solution dried over MgSO4 and purified with column chromatography using hex-
ane as eluent. The product (30.0 g, 81%) a slightly orange oil consists of two isomers in a ratio of 63:37.
1H-NMR (300 MHz, CDCl3): Major isomer δ = 2.41 (q, J = 6.8 Hz, 4 H), 2.79–2.87 (m, 4 H), 6.09 (t, J = 7.1 Hz, 
2 H). Minor isomer δ = 2.31–2.37 (m, 4 H), 2.91 (s, 4 H), 6.00–6.05 (m, 2 H).
13C-NMR (75 MHz, CDCl3): Major isomer δ = 27.56, 38.43, 124.56, 129.67. Minor isomer δ = 27.80, 38.17, 
123.95, 129.99.
Carboxymethylmonobenzobromocyclooctene (3). Hexane (100 ml) was added to [18]-crown-6 
ether (4.0 g, 0.015 mol). To this mixture first KOtBu (80.0 g, 0.71 mol) and then hexane (200 ml) was added. 
Dibromocycloocta-1,5-diene (2) (30.0 g, 0.11 mol) was dissolved in hexane (200 ml) added to the reaction mix-
ture and stirred for 1.5 h at room temperature. A saturated aqueous NH4Cl solution and water were added for 
extraction. After separation the combined organic layers were dried over MgSO4 and given in a clean flask. Methyl 
coumalate (6.0 g, 0.039 mol) was also added into the flask and stirred overnight. The solvent was evaporated and 
the crude product purified with column chromatography using hexane with 3% EtOAc as eluent to get a slightly 
orange oil (8.0 g, 25%).
1H-NMR (300 MHz, CDCl3): δ = 2.41–2.55 (m, 4 H), 2.96–3.16 (m, 8 H), 3.89 (s, 3 H), 3.90 (s, 3 H), 5.78–5.87 
(m, 2 H), 7.11 (d, J = 7.9 Hz, 1 H), 7.18 (d, J = 8.5 Hz, 1 H), 7.74 (d, J = 1.6 Hz, 1 H), 7.77–7.85 (m, 3 H).
13C-NMR (75 MHz, CDCl3): δ = 29.62, 29.79, 32.96, 33.22, 33.27, 33.36, 39.19, 39.54, 52.11, 123.67, 124.02, 
127.86, 128.07, 128.50, 128.70, 130.00, 130.23, 130.33, 130.76, 131.36, 131.79, 139.02, 139.76, 144.32, 145.08, 
167.29.
Carboxymethylmonobenzocyclooctin (COMBO) (4). Hexane (160 ml) was added to a mixture 
of [18]-crown-6 ether (100 mg, 0.38 mmol) and KOtBu (420 mg, 3.74 mmol). This suspension was heated to 
58–60 °C then carboxymethylmonobenzobromocyclooctene (3) (440 mg, 1.50 mmol) was dissolved in hexane 
(60 ml) and added to the suspension. The reaction mixture was stirred for 90 min. After cooling to room temper-
ature the insoluble particles were filtered off and washed with EtOAc. Ice was added. Then the two phases were 
separated and the organic phase was washed with water. An aqueous solution of AgNO3 (0.5 M) was added to the 
organic phase and shaken for 5 minutes. The collected aqueous phases were washed with hexane. Then a cooled 
ammonia solution (25%) and hexane were added. After separation the aqueous phase was again extracted with 
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hexane. The combined organic layers were dried over MgSO4 and the solvent was evaporated yielding the desired 
product (90 mg, 29%) as colorless oil.
1H-NMR (300 MHz, CDCl3): δ = 2.20–2.39 (m, 2 H), 2.40–2.54 (m, 2 H), 2.82–2.97 (m, 2 H), 3.34–3.52 (m, 
2 H), 3.90 (s, 3 H), 7.20–7.25 (m, 1 H), 7.79–7.92 (m, 2 H).
13C-NMR (75 MHz, CDCl3): δ = 22.61, 22.81, 37.61, 37.74, 52.12, 99.00, 99.41, 127.93, 128.59, 131.12, 132.03, 
141.57, 146.86, 167.20.
COMBO acid (5). COMBO (4) (90 mg, 0.42 mmol) was dissolved in dioxane (7.0 ml). LiOH (200 mg, 
8.35 mmol) was dissolved in water (3.0 ml) and added dropwise36. The reaction mixture was heated to 30 °C 
and stirred for 2 h. HCl (1 N) was added first and then CH2Cl2. The two phases were mixed and separated. The 
aqueous phase was extracted with CH2Cl2. The combined organic layers were dried over MgSO4. The solvent was 
evaporated and the residue washed with hexane to get a white solid (50 mg, 60%).
1H-NMR (300 MHz, 1,4-dioxane-d8): δ = 2.17–2.34 (m, 2 H), 2.34–2.48 (m, 2 H), 2.80–2.95 (m, 2 H), 3.34–
3.49 (m, 2 H), 7.21–7.29 (d, J = 7.9 Hz, 1 H), 7.77–7.82 (dd, J = 1.9 Hz, J = 7.9 Hz, 1 H), 7.82–7.85 (d, J = 1.9 Hz, 
1 H), 10.58 (bs, 1 H).
13C-NMR (75 MHz, 1,4-dioxane-d8): δ = 22.78, 22.95, 37.98, 38.16, 99.51, 100.05, 128.64, 129.53, 131.69, 
132.84, 142.58, 147.67, 167.52.
COMBO-tetraethylene glycol-COMBO (6). CH2Cl2 (2.0 ml) was added to tetraethylene gly-
col (20 mg, 0.10 mmol) and cooled to 0 °C. COMBO acid (5) (50 mg, 0.25 mmol) was added and stirred for 
15 min. N-(3-dimethylaminopropyl)-N´-ethylcarbodiimide hydrochloride (EDC) (58 mg, 0.30 mmol) and 
4-dimethylaminopyridine (DMAP) (8 mg, 0.06 mmol) were dissolved in CH2Cl2 (1.0 ml) and added to the reac-
tion mixture. The mixture was stirred for another 15 min at 0 °C then at room temperature overnight. CH2Cl2 and 
a saturated aqueous NH4Cl solution were added, mixed and the two phases were separated. The organic phase was 
washed with a saturated aqueous NaHCO3- and NaCl solution and dried over MgSO4. The solvent was evaporated 
and the crude product purified with column chromatography using CH2Cl2 with 1% MeOH as eluent to yield a 
colorless oil (50 mg, 36%).
1H-NMR (300 MHz, CDCl3): δ = 2.21–2.38 (m, 4 H), 2.40–2.54 (m, 4 H), 2.83–2.96 (m, 4 H), 3.46–3.52 (m, 
4 H), 3.64–3.74 (m, 8 H), 3.78–3.86 (m, 4 H), 4.42–4.51 (m, 4 H), 7.22 (d, J = 8.5 Hz, 2 H), 7.84–7.90 (m, 4 H).
13C-NMR (75 MHz, CDCl3): δ = 22.53, 22.72, 37.47, 37.65, 64.02, 69.31, 70.72, 98.91, 99.32, 127.98, 128.45, 
131.00, 132.00, 141.48, 146.88, 166.52.
Staudinger ligation and strain-promoted cycloaddition. The modification of cell-free synthesized 
EGFR-eYFP with incorporated AzF at position 687 by Staudinger ligation with DyLight650 phosphine (Pierce) 
was carried out as previously described6.
The covalent cross-linking of receptor monomers with AzF incorporated in the intracellular juxtamembrane 
region using the bis-COMBO linker was performed on microsomal fractions enriched with receptors by four 
consecutive cell-free reactions. Therefore, 5 μ l aliquots of the microsomal fractions were resuspended in 20 μ l 
kinase buffer without ATP containing 10 μ M of the freshly dissolved linker. Samples were incubated for 2 hour at 
25 °C and subsequently centrifuged to collect the microsomes. Microsomes were then subjected to the tyrosine 
kinase assay in the presence or absence of ATP as described above followed by denaturing PAGE, immunoblot-
ting and autoradiography.
Denaturing PAGE, in-gel fluorescence, immunoblotting and autoradiography. Sample prepara-
tion including cold acetone precipitation followed by denaturing PAGE using NuPAGE 10% Bis-Tris and 3–8% 
Tris-Acetate precast gels (Life Technologies) as well as detection of in-gel fluorescence and autoradiography were 
performed as described previously and in accordance to the manufacturer’s instructions6. Due to increased pro-
tein concentrations resulting from utilization of the CrPV-IRES the amount of sample applied to the denaturing 
page was reduced to correspond to 2.5 μ l of the initial fractions from the cell-free reactions.
Immunoblotting was performed using the “IBlot Gel Transfer Device” (Life Technologies) according to 
the manufacturer’s instructions. Following denaturing PAGE (3–8% Tris-Acetate) proteins were transferred 
to a PVDF membrane (Life Technologies). The membrane was blocked in “Roti-Block” (Roth) for 4 hours and 
subsequently incubated with “EGF Receptor (D38B1) XP® Rabbit mAb 4267” or “Phospho-EGF Receptor 
(Tyr1068) (D7A5) XP® Rabbit mAb 3777” primary antibodies diluted 1:1000 over night at 4 °C. “Anti-rabbit 
IgG, HRP-linked Antibody 7074” diluted 1:2000 was used as a secondary antibody and detection was carried 
out using the “Amersham ECL Prime Western Blotting Detection Reagent” (GE Healthcare) and the “Typhoon 
Trio + Variable Mode Imager” (GE Healthcare). All antibodies were purchased from “Cell Signaling Technology 
Inc.”. After detection, blotting membranes were dried and subjected to autoradiography.
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